Parth Patel, PA
Medical · Philadelphia, PANPI 1447744453
Payments from drug & device makers
Across 560 payments — averaging $81.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$36K
- AbbVie$2K
- Arcutis Biotherapeutics, Inc.$1K
- LEO Pharma Inc.$838
- Sanofi$768
- Lilly USA, LLC$719
- plus $4K from 20 others
What the payments were for
- Consulting fees$2,1135%
- Speaking & faculty fees$27,72661%
- Travel & lodging$2,7816%
- Food & beverage$12,61828%
- Education$4411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 161 | $36,066 |
| AbbVie | 91 | $1,670 |
| Arcutis Biotherapeutics, Inc. | 5 | $1,234 |
| LEO Pharma Inc. | 28 | $838 |
| Sanofi | 26 | $768 |
| Lilly USA, LLC | 39 | $719 |
| Sun Pharmaceutical Industries Inc. | 33 | $610 |
| Regeneron Healthcare Solutions, Inc. | 26 | $594 |
| Novartis | 25 | $559 |
| UCB, Inc. | 12 | $402 |
| Dermavant Sciences, Inc. | 16 | $321 |
| Amgen | 16 | $307 |
| Incyte Corporation | 18 | $303 |
| Mayne Pharma Commercial LLC | 13 | $279 |
| Janssen Scientific Affairs, LLC | 5 | $245 |
| Organon | 14 | $186 |
| Paratek Pharmaceuticals, Inc. | 8 | $150 |
| Botanix SB Inc | 9 | $136 |
| E.r. Squibb & Sons, L.L.C. | 4 | $75 |
| Galderma Laboratories, L.p. | 3 | $56 |
| Boehringer Ingelheim | 2 | $42 |
| Pfizer | 2 | $36 |
| Cipher Pharmaceuticals US LLC | 1 | $30 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Journey Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$45,679 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 74 | $5,934 |
| Clobetasol Propionate | 142 | $4,664 |
| Ketoconazole | 264 | $4,277 |
| Clindamycin Phosphate | 63 | $1,912 |
| Betamethasone Dipropionate | 53 | $1,856 |
| Ammonium Lactate | 104 | $1,751 |
| Triamcinolone Acetonide | 159 | $1,332 |
| Mometasone Furoate | 77 | $1,113 |
| Metronidazole | 26 | $969 |
| Doxycycline Hyclate | 68 | $844 |
| Mupirocin | 80 | $623 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 20 | $577 |
| Hydrocortisone | 91 | $503 |
| Betamethasone Valerate | 11 | $376 |
| Ciclopirox | 13 | $328 |
Paid to pharmacies, not to this prescriber.
Other medical in Philadelphia
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Sarah SmithPhiladelphia$65K
- Victoria WongPhiladelphia$51K
- Zachary LutzPhiladelphia$30K
- Hawah MusaPhiladelphia$13K
- Carl BlackPhiladelphia$13K
- Ashley BarratPhiladelphia$12K
- Jacqueline KernaghanSpringfield$427K
- Drew SodaNew Hope$220K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.